Breakthrough in Triple-Negative Breast Cancer Treatment Shows Promise with Ferroptosis Therapy

Strategic Insights -

New research out of Fudan University in Shanghai, China, has made a significant breakthrough in the treatment of triple-negative breast cancer (TNBC), a highly aggressive and deadly form of the disease. The study, published in the Journal of Materials Chemistry B, demonstrates the efficacy of combining chemotherapy with ferroptosis therapy, a non-apoptotic form of cell death, to induce significant cytotoxicity against TNBC cell lines.

Key Takeaways:

  • The research found that ferroptosis, a non-apoptotic form of cell death, is closely associated with the occurrence and development of TNBC.
  • The team developed a zwitterionic polymer-coated magnetic composite nanoparticle (FeO@PSBMA-GNA) that achieved significant cytotoxicity against TNBC cell lines.
  • FeO@PSBMA-GNA induced apoptosis through the inhibition of Bcl-2 and triggered ferroptosis by inhibiting the PI3K/AKT/mTOR/GPX4 pathway in MDA-MB-231 cells simultaneously.
  • The nanoparticles showed excellent blood circulation performance, leading to enhanced tumor accumulation and a satisfactory tumor suppression effect on MDA-MB-231 tumor-bearing mice.
  • This strategy of chemotherapy combined with ferroptosis therapy is expected to be a feasible treatment for refractory TNBC.
  • The study has been peer-reviewed and published in the Journal of Materials Chemistry B.
  • Additional authors for this research include Jingbo Lin, Chenxi Li, Shaoqi Sheng, Yichen Zhang, and Wuli Yang.

Statistics:

  • 30% of breast cancer cases are classified as triple-negative, with a high risk of metastasis and recurrence.
  • Ferroptosis is primarily caused by excessive accumulation of lipid peroxides and is closely associated with the occurrence and development of TNBC.

Sources:

  • Zwitterionic polymer-coated magnetic nanoparticle induced chemotherapy and ferroptosis for triple-negative breast cancer therapy. Journal of Materials Chemistry B, 2025.
  • NewsRx. Fudan University Reports Findings in Breast Cancer (Zwitterionic polymer-coated magnetic nanoparticle induced chemotherapy and ferroptosis for triple-negative breast cancer therapy). Nanotechnology Weekly. May 12, 2025; p 2202.